Lansoprazole Teva

Lansoprazole, the active ingredient in Lansoprazole Teva, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of gastro‑esophageal reflux disease, peptic ulcer disease and in combination regimens for Helicobacter pylori eradication.

GNH USA supplies Lansoprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides efficient, reliable logistics for worldwide distribution.

Lansoprazole is a proton pump inhibitor used to manage conditions associated with excess gastric acid.

- Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate headache often occurring early in therapy. - Diarrhea: loose stools that may be watery. - Nausea: feeling of sickness, sometimes with vomiting. - Abdominal pain: mild stomach discomfort or cramping. - Flatulence: increased intestinal gas and bloating. - Constipation: reduced bowel movements and hard stools.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Hypomagnesemia: low magnesium levels that can cause muscle cramps. - Vitamin B12 deficiency: anemia and neurological symptoms with prolonged use. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Stevens‑Johnson syndrome: severe skin reactions with blistering and mucosal involvement. - Pancreatitis: inflammation of the pancreas causing upper abdominal pain.

Before prescribing Lansoprazole, clinicians should consider several precautionary measures to ensure safe use. - Assess renal function: adjust use in severe renal impairment. - Monitor electrolytes: watch for low magnesium and potassium. - Evaluate bone health: long‑term use may increase fracture risk. - Consider infection risk: prolonged acid suppression can predispose to gastrointestinal infections. - Pregnancy and lactation: use only if benefits outweigh risks. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Lansoprazole can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect; avoid concurrent use. - Atazanavir and other protease inhibitors: decreased absorption; avoid. - Methotrexate (high dose): increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Diazepam: increased serum levels; adjust dose if needed. - Digoxin: modest increase in concentration; observe for toxicity.